logo
Donated brain thrown out; Children's Wisconsin 'profoundly sorry'

Donated brain thrown out; Children's Wisconsin 'profoundly sorry'

Yahoo08-05-2025

Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Generate Key Takeaways
The Brief
Children's Wisconsin says it accidentally 'discarded' the frozen portion of a young woman's donated brain.
Ashtyn Fellenz, who died in December, underwent pioneering gene therapy 21 years ago.
The doctor who conducted the surgery in 2003 said the lost brain tissue was vital for ongoing gene therapy research.
WAUWATOSA, Wis. - When 24-year-old Ashtyn Fellenz died on December 5, 2024, the dry ice was waiting. She was already at Children's Wisconsin where a pathologist was prepared to carefully extract her brain and preserve it for future research.
A 'tremendous' loss
What we know
By all accounts, the extraction of her brain was flawless. It was separated into hemispheres - half of it chemically fixated in a formalin solution, the other half segmented and rapidly frozen. The plan was to quickly ship both halves to a Living BioBank at Children's Hospital in Dayton, Ohio. Instead, the tissue sat in a Children's Wisconsin laboratory for months.
Ashtyn Fellenz died on December 5, 2024, at age 24
Eventually, after internal administrative changes and a laboratory move, hospital officials discovered the frozen half of Ashtyn's brain had been accidentally "discarded."
The discovery stunned not only the Fellenz family, but the researcher who had requested the brain be preserved – Dr. Paola Leone.
"The loss is tremendous," Leone said.
A silent life
The backstory
Ashtyn was born on June 15, 2000, apparently healthy. By six months of age, her parents knew something was seriously wrong.
"She started missing milestones, not being able to lift up her head," said her father, Scott Fellenz.
Ashtyn was diagnosed with Canavan Disease, a rare genetic disorder that causes degeneration of the protective coating around nerves and a loss of white matter in the brain. Children with Canavan progressively lose the ability to use their muscles and become trapped inside their own bodies, like a living rag doll. Without intervention, most children with the disease die before age 10.
Just after her 3rd birthday, Ashtyn received gene therapy through a viral vector injected directly into her brain. The pioneering surgery was aimed at replacing the defective gene that causes Canavan disease with a functional gene.
In 2003, Ashtyn underwent pioneering surgery to inject a functional gene into her brain in hopes of replacing the defective one. The experimental gene therapy did not cure the disease, but Dr. Leone said it improved her quality of life and helped her survive until age 24.
"That sounds like a success," said FOX6 Investigator Bryan Polcyn.
"It is a success," Dr. Leone replied.
FREE DOWNLOAD: Get breaking news alerts in the FOX LOCAL Mobile app for iOS or Android
Ashtyn never spoke a word in her life, but Dr. Leone said there was a treasure trove of information inside her brain.
"In that silence, there was so much knowledge," the doctor said.
A big part of her legacy
What they're saying
Asthyn was one of 16 children to get the experimental treatment, but Dr. Leone said she is one of the rare Canavan patients to have died under optimal circumstances for preserving her brain.
"Most Canavan patients die at home," the doctor said. By the time their bodies are available for autopsy, the brain tissue has degraded significantly. Asthyn died at Children's Wisconsin.
"The scenario was perfect," Dr. Leone said. "She was in the hospital. The dry ice was there, ready to go."
Dr. Paola Leone, now a professor at Rowan University in New Jersey, performed the surgery in 2003.
Ashtyn's family had long ago agreed to donate her brain for research.
"I knew that's what we wanted to do," said Arlo Fellens, Ashtyn's mother.
"It was no question that we had to do that," said Scott Fellenz, her father. "It was a big part of her legacy."
Unexplained delays
Timeline
When Ashtyn died on Dec. 5, Children's Wisconsin determined that a previous consent form signed by her parents was outdated. Before the hospital could ship the brain to Ohio, they would need a new one.
Dr. Leone sent the updated consent hours before boarding a flight to Wisconsin to deliver a eulogy at Ashtyn's funeral.
"Her powerful voice encrypted in her DNA will deliver life-saving messages," Dr. Leone told a packed Pewaukee church, still believing the brain would soon be ready for her to evaluate.
What happened next is detailed in a series of emails between Dr. Leone and a pathologist at Children's.
"I mean, I gave the address, the FedEx number," Dr. Leone said. "Everything was ready to go."
Dr. Leone flew to Wisconsin to delivery a eulogy at Ashtyn's funeral on December 7, 2024
More than a month passed without any shipment.
On Jan. 13, Dr. Lauren Parsons, Director of Pathology at Children's Wisconsin, wrote an email thanking Dr. Leone for her "patience," adding that "holidays and some leadership transitions" had kept her busy.
Dr. Parsons wrote, "I fully endorse sending the brain" to Ohio. But two more months passed – still nothing.
"We follow up with emails, no reply," Dr. Leone said. "Other emails, no reply."
"She literally ghosted her for two months," Scott Fellenz said.
SIGN UP TODAY: Get daily headlines, breaking news emails from FOX6 News
Finally, in March, Arlo Fellenz contacted the hospital for answers. She received a call back from "grief services," asking to set up a meeting. Arlo knew the news would not be good, so she demanded to hear about it over the phone.
"They regret to tell me it was, her brain was disposed of," Arlo recalled hearing
"They threw your daughter's brain away," said FOX6 Investigator Bryan Polcyn.
"Yeah, that's what it comes down to," Arlo said. "They tossed out her brain. How can you do that with a brain?"
Actually, half of Ashtyn's brain was eventually shipped to Ohio – the fixed portion.
But it was the frozen half that was inadvertently thrown away. Dr. Leone said that was the most valuable part for research purposes.
"And I was like, 'How could you discard something so valuable?,' Arlo Fellenz said. "And they kept just saying, 'Well we're sorry. We just, it was just disposed of, we can't tell you anything more.'"
"It was literally like losing Ashtyn all over again," Scott Fellenz said.
It's irreplaceable
Dig deeper
For Dr. Leone, the loss is both personal and professional.
"When Ashton passed away we were all heartbroken," the doctor said.
Beyond the emotional ties she had to Ashtyn, Dr. Leone said the post-mortem examination of her brain would have offered unparalleled insights into how the gene therapy worked inside Ashtyn.
Arlo and Scott Fellenz have hired attorney James Gende to represent them.
"This would have just led, just paved the way for any other application of gene therapy into the brain to let us know if gene therapy can persist," the doctor said.
Dr. Leone said it would most likely have resulted in a "high-impact" publication that could have served future research.
"It's a loss of information that would have been precious and cited for the years to come, for the centuries to come, because this is the one and only specimen, not just for Canavan, for any other gene therapy," the doctor said. "It's irreplaceable."
We are 'profoundly sorry'
The other side
Children's Wisconsin declined a request for an on-camera interview. In a statement emailed to FOX6 Investigators, a spokesperson writes:
"We were honored to support Ashtyn's family's wish for her legacy to help others. As we communicated to the family when this error was discovered, and reiterate now, our team is profoundly sorry this happened, and we continue to take steps to reinforce our protocols to help ensure this does not occur again. The availability of human tissue to support life-changing and lifesaving medical research is critical to offering hope to families. We take seriously our work to support research through proper tissue collection, storage and usage. We are deeply grateful for Ashtyn's life and for her family's advocacy and care, and again offer our most sincere regret and apology."
After receiving the statement, FOX6 Investigators submitted 16 written questions to Children's Wisconsin seeking further detail. The hospital responded with this:
"As this situation is under the threat of litigation, and due to patient privacy matters, we are unable to respond in detail to many of your questions. We share the following in the hope it provides additional context:
We have comprehensive processes in place to properly manage tissue donated for research purposes. Aspects of those processes were not followed, which caused this error.
We realized this error as the sample was being prepared for shipment. While one portion of the tissue remained, it became apparent that the separate frozen portion of the tissue was erroneously disposed of.
To your question regarding timing, it appears several matters created the gap in time from when the autopsy occurred to when the tissue was approved for shipment (which is when we realized a portion was accidentally disposed of). Those factors included time needed to secure and review correct consent forms from the receiving institution, the move of the lab and various scheduling matters.
The change in lab leadership had no bearing on this matter.
None of the above is an excuse for the remaining tissue sample being accidentally disposed of and for the delay in realizing and communicating this error.
We have taken several specific steps to learn from this, including:The team has participated in re-education on our processes.This matter is being prioritized as it proceeds through our internal quality review process.Should the quality review process identify other areas for improvement, we will address those improvements with the seriousness they deserve.
The team has participated in re-education on our processes.
This matter is being prioritized as it proceeds through our internal quality review process.
Should the quality review process identify other areas for improvement, we will address those improvements with the seriousness they deserve.
This was a very unique situation. We cannot recall any previous situation where organ tissue donated for medical research was erroneously discarded."
Lawsuit imminent
What's next
The Fellenz family has hired attorney James Gende to represent them. If Asthyn's brain can't help with Canavan research, her family said perhaps money will.
"Then Ashtyn can have some meaning in her life after her death."
The family has set up a separate fund at St. Bartholomew's Episcopal Church in Pewaukee. According to the website, Ashtyn's Hope supports families and children with Canavan Disease with medical equipment.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ibogaine by David Dardashti Announces Landmark Initiative with Google Chrome Team to Enhance Patient Security and Aftercare
Ibogaine by David Dardashti Announces Landmark Initiative with Google Chrome Team to Enhance Patient Security and Aftercare

Associated Press

timean hour ago

  • Associated Press

Ibogaine by David Dardashti Announces Landmark Initiative with Google Chrome Team to Enhance Patient Security and Aftercare

MIAMI, FL - June 10, 2025 - Ibogaine by David Dardashti, a leader in innovative wellness and treatment solutions, today announced a forward-thinking initiative following pivotal discussions with members of the Google Chrome team at their Miami, Florida office. The clinic will integrate Chrome's advanced cloud and security technologies to fundamentally enhance its operational framework and patient care protocols, setting a new standard for security and long-term patient success in the treatment industry. The decision follows a collaborative meeting between Gavriel Dardashti and the Google Chrome team, where they explored the future of secure, cloud-first operating systems in a clinical environment. Recognizing the critical need for robust data protection and efficient digital infrastructure, the clinic has committed to a comprehensive implementation of ChromeOS and associated Google technologies. This transition will create a secure, unified ecosystem that safeguards sensitive patient information with Google's world-class security architecture while streamlining both administrative and clinical processes through highly efficient cloud computing. The technological integration extends directly into the clinic's pioneering treatment methodologies. During a patient's stay, the new systems will ensure all digital interactions and data entry points are secure and seamless. More importantly, the initiative introduces a revolutionary approach to post-treatment support, a critical phase in a patient's journey. 'This isn't just about upgrading our IT systems; it's about upgrading our standard of care,' said Gavriel Dardashti, son of the founder of the clinic. 'By harnessing the power and security of Google's cloud ecosystem, we can provide our patients with a safer, more connected, and more supportive recovery journey. Our goal is to use this technology to stay engaged with our patients long after they leave our facility, giving them the tools and the confidence to achieve lasting success. This collaboration allows us to build a more resilient and effective model for aftercare.' By leveraging ChromeOS, the clinic will provide patients with tools and platforms to monitor their progress and maintain a connection to their support network. The utilization of Google's cloud technologies will enable secure data monitoring and communication, offering insights into patient success and allowing for timely intervention and encouragement. This data-driven approach aims to ensure greater long-term success rates and provide a continuum of care that extends far beyond the clinic's walls. About Ibogaine by David Dardashti: Ibogaine by David Dardashti is a premier treatment center dedicated to providing innovative and effective paths to recovery. The clinic is committed to a holistic approach that integrates cutting-edge science with compassionate, individualized care. Its mission is to empower individuals to overcome their challenges and build a foundation for a healthy, successful, and sustainable future. Media Contact Company Name: Ibogaine By David Dardashti Contact Person: Cole Barressi Email: Send Email Country: United States Website: Press Release Distributed by To view the original version on ABNewswire visit: Ibogaine by David Dardashti Announces Landmark Initiative with Google Chrome Team to Enhance Patient Security and Aftercare

Teva Honored With Power of Partnership Award for Global Health Impact
Teva Honored With Power of Partnership Award for Global Health Impact

Associated Press

timean hour ago

  • Associated Press

Teva Honored With Power of Partnership Award for Global Health Impact

Teva Pharmaceuticals has been recognized with the 2025 Power of Partnership Award by Americares, in collaboration with the Healthcare Distribution Alliance (HDA), for its exceptional commitment to expanding access to medicines for underserved communities around the world. The award was presented to Carol Richardson, Teva's U.S. Head of Sustainability and Health Equity, during the HDA Business and Leadership Conference in Orlando, Florida, on June 2. A Legacy of Giving Teva's partnership with Americares spans nearly three decades, during which the company has donated enough medicine to fill nearly 19 million prescriptions. In 2024 alone, Teva contributed $48 million worth of essential medicines to Americares to support health centers in low- and middle-income countries. These donations have reached 124 countries, providing treatments for respiratory illnesses, hypertension, diabetes, depression, and more. Teva's support has also been critical in disaster response efforts, including the 2010 Haiti earthquake, flooding in the Philippines, and the ongoing humanitarian crisis in Ukraine. 'Expanding access to medicines for underserved populations is a core element of Teva's Healthy Future sustainability strategy,' said Richardson. 'Teva is honored to receive this prestigious recognition from Americares, our longstanding partner, and we look forward to continuing our work together to help provide quality care to people in need around the world.' Innovation in Access In 2024, Teva launched a produce-to-give program, creating a dedicated supply of essential medicines for three Americares partner health facilities in El Salvador. In its first year, the program delivered enough medicine to fill over 13,500 prescriptions, addressing infections, cardiovascular disease, and gastrointestinal conditions. Recognizing Impact 'Teva is one of Americares most dedicated and longstanding supporters,' said Dr. Adam Schwartz, Deputy Medical Officer at Americares. 'With Teva's support, we are increasing access to health for people and communities in need all over the world.' HDA President and CEO Chester 'Chip' Davis, Jr. added, 'We applaud Teva's work with Americares to donate lifesaving medicines to patients worldwide, as well as Teva's commitment to enhancing health outcomes for individuals.'

EY US names Tribal Health CEO Morgan Haynes as an Entrepreneur of the Year® 2025 Pacific Southwest Award finalist
EY US names Tribal Health CEO Morgan Haynes as an Entrepreneur of the Year® 2025 Pacific Southwest Award finalist

Associated Press

timean hour ago

  • Associated Press

EY US names Tribal Health CEO Morgan Haynes as an Entrepreneur of the Year® 2025 Pacific Southwest Award finalist

Entrepreneur of the Year celebrates ambitious entrepreneurs who are shaping the future 'Morgan's relentless pursuit of healthcare excellence on Indigenous lands has made a transformative impact across patient outcomes and our service communities. '— Ashley Sanders, CFO SCOTTSDALE, AZ, UNITED STATES, June 10, 2025 / / -- Ernst & Young LLP (EY US) announced the finalists for the prestigious Entrepreneur of the Year 2025 Pacific Southwest Award. Now in its 40th year, the Entrepreneur of the Year program celebrates the bold leaders who disrupt their industries through groundbreaking achievements while making a profound impact on their communities. The program honors bold entrepreneurs whose innovations shape the future and pave the way for a thriving economy and a hopeful tomorrow. An independent panel of judges selected Tribal Health CEO Morgan Haynes for her entrepreneurial spirit, strength of purpose, and her lasting impact in driving year-over-year growth. 'We founded Tribal Health to bring exceptional healthcare to underserved Tribal nations,' said Haynes. 'From making a meaningful impact in Indigenous health to watching our momentum grow, entrepreneurship has been a challenging, exciting, and rewarding endeavor. On behalf of our incredible team spanning more than 37 states, I'm honored to receive such prestigious recognition. It's made all the more significant by the impressive caliber of my fellow finalists.' Entrepreneur of the Year honors business leaders for their ingenuity, courage and entrepreneurial spirit. The program celebrates original founders who bootstrapped their business from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory; and multigenerational family business leaders who reimagined a legacy business model to build a stronger future. 'Our financial growth and industry success is a testament to Morgan's leadership,' said Ashley Sanders, Chief Financial Officer at Tribal Heath. 'Her relentless pursuit of healthcare excellence on Indigenous lands has made a transformative impact across patient outcomes and our service communities. Because of her dedication, we have significantly expanded our capabilities and developed new healthcare staffing solutions that drive clinical improvements and operational stability. In fostering a culture of innovation across all aspects of Indigenous healthcare, her entrepreneurial journey has been an inspiration to us all.' Haynes, along with other pacific southwest regional finalists, was recognized on June 6 during a special celebration announcing the award winners in San Diego. About Entrepreneur of the Year Founded in 1986, Entrepreneur of the Year has celebrated more than 11,000 ambitious visionaries who are leading successful, dynamic businesses in the US, and it has since expanded to nearly 60 countries globally. The US program consists of 17 regional programs whose panels of independent judges select the regional award winners every June. Those winners compete for national recognition at the Strategic Growth Forum® in November where National finalists and award winners are announced. The overall National winner represents the US at the EY World Entrepreneur of the Year™ competition. Visit About Tribal Health Tribal Health provides emergency medicine, critical care, specialty, primary and behavioral health care as well as consulting and staffing services to Tribal and federal healthcare facilities nationwide. The only organization of its kind, Tribal Health is committed to transforming Native American and Indigenous communities from within, improving access to care, creating health care career opportunities, empowering providers, and delivering high quality, culturally sensitive care that is tailored to Indigenous needs. Learn more at About EY EY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets. Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow. EY teams work across a full spectrum of services in assurance, consulting, tax, strategy and transactions. Fueled by sector insights, a globally connected, multi-disciplinary network and diverse ecosystem partners, EY teams can provide services in more than 150 countries and territories. All in to shape the future with confidence. EY refers to the global organization, and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit Valerie Fenyn Tribal Health + 16022064847 email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store